Log In
BCIQ
Print this Print this
 

Toll-like receptor 9 (TLR9)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Toll-like receptor 9 (TLR9)

BCIQ
Print ChartPrint this
Phase III, 1 Phase III, 1 Phase III, 1 Phase III, 1 Phase II, 1 Phase II, 1 Phase II, 3 Phase II, 2 Phase I/II, 1 Phase I/II, 3 Phase I, 3 Phase I, 1 Phase I, 4 Phase I, 2 Preclinical, 1 Preclinical, 1 Preclinical, 2 Preclinical, 1 Preclinical, 2 Preclinical, 1 Discovery, 1
Phase of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase IIPhase III
Autoimmune

-

1

2

-

2

1

Cancer

-

2

4

3

3

1

Cardiovascular

1

1

-

-

-

-

Endocrine / Metabolic

-

2

-

-

-

-

Infectious

-

-

1

1

-

1

Inflammation

-

1

3

-

1

-

Neurology

-

-

-

-

1

-

Other

-

-

-

-

-

1

Pulmonary

-

1

-

-

-

-




 Products Targeting Toll-like receptor 9 (TLR9)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

8

$849.6M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today